LCI Key Stats
- LANNETT CO INC Financials May 17
- Socially Responsible Investing in Biotech and Pharmaceutical Companies: Expert P... May 16
- Isis Gets $3.5M Milestone Payment May 14
- Isis Gets $3.5M Milestone Payment - Analyst Blog Zacks May 14
- Narrower-than-Expected Loss at Supernus May 14
- NPS Pharma Incurs Narrower 1Q Loss - Analyst Blog Zacks May 14
- Narrower-than-Expected Loss at Supernus - Analyst Blog Zacks May 14
- Setback for Endo Health on Opana ER May 13
- Setback for Endo Health on Opana ER - Analyst Blog Zacks May 13
- Did These Stocks Miss or Beat Analyst Expectations? May 12
LCI Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Lannett Company is up 215.1% over the last year vs S&P 500 Total Return up 30.71%, Catalyst Pharmaceutical Partners down 4.50%, and Santarus up 277.8%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Pro Ratings for LCI
Pro Report PDF for LCI
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download LCI Pro Report PDF
Pro Strategies Featuring LCI
Did Lannett Company make it into our Pro Portfolio Strategies?